ecadotril

Known as: acetorphan, (S)-isomer, sinorphan 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2014
02419902014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Neutral endopeptidase 24.11 (NEP) inhibitors are known to have vascular, diuretic, and natriuretic effects that may be helpful in… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Is this relevant?
2000
2000
OBJECTIVE To determine the toxicity of ecadotril in dogs. ANIMALS 74 healthy 4- to 11-month-old Beagles. PROCEDURE To… (More)
Is this relevant?
1999
1999
OBJECTIVE To determine the short-term safety and tolerability of the addition of ecadotril to conventional therapy in patients… (More)
Is this relevant?
1998
1998
Cardiac hypertrophy develops to compensate for hemodynamic overload of the myocardium. However, cardiac hypertrophy itself poses… (More)
Is this relevant?
1995
1995
OBJECTIVE To evaluate the antihypertensive efficacy of sinorphan, an orally active inhibitor of neutral endopeptidase EC 3.4.24… (More)
Is this relevant?
1994
1994
The acute renal effects of neutral endopeptidase 24.11 (E-24.11) inhibition induced by a single oral dose of sinorphan (100 mg… (More)
Is this relevant?
1993
1993
1. The acute effects of a single oral dose of sinorphan (100 mg), an inhibitor of neutral endopeptidase, on the plasma atrial… (More)
Is this relevant?
1991
1991
We examined the acute effects of sinorphan, an inhibitor of enkephalinase, on plasma atrial natriuretic factor (ANF) and urinary… (More)
Is this relevant?